Evidence map›Paper›PMID 23474212›Full record

ReviewPulmonary pharmacology & therapeutics2013

Pre-clinical studies in cough research: role of Transient Receptor Potential (TRP) channels.

Megan S Grace, Eric Dubuis, Mark A Birrell, Maria G Belvisi

Open access · hybridAbstract readReview
In one paragraph

Review in Pulmonary pharmacology & therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 70 citations in OpenAlex.

  1. Modulation of TRPV-1 by prostaglandin-EScientific reports · 2020
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Prostaglandin ERespiratory research · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Methods for assessing cough sensitivity.Journal of thoracic disease · 2020
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Blocking TRPA1 in Respiratory Disorders: Does It Hold a Promise?Pharmaceuticals (Basel, Switzerland) · 2016
    Review
  20. TRPV1 and TRPM8 in Treatment of Chronic Cough.Pharmaceuticals (Basel, Switzerland) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Megan S GraceRespiratory Pharmacology, Pharmacology & Toxicology Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Exhibition Road, London SW7 2AZ, UK.
Eric Dubuis
Mark A Birrell
Maria G Belvisi
Imperial College London · GBUniversity of Manchester · GB

Funding

Medical Research Council G0800195Medical Research Council MR/K020293/1
6 · The paper itself

Abstract

Cough is a protective reflex and defence mechanism in healthy individuals, which helps clear excessive secretions and foreign material from the lungs. Cough often presents as the first and most persistent symptom of many respiratory diseases and some non-respiratory disorders, but can also be idiopathic, and is a common respiratory complaint for which medical attention is sought. Chronic cough of various aetiologies is a regular presentation to specialist respiratory clinics, and is reported as a troublesome symptom by a significant proportion of the population. Despite this, the treatment options for cough are limited. The lack of effective anti-tussives likely stems from our incomplete understanding of how the tussive reflex is mediated. However, research over the last decade has begun to shed some light on the mechanisms which provoke cough, and may ultimately provide us with better anti-tussive therapies. This review will focus on the in vitro and in vivo models that are currently used to further our understanding of the sensory innervation of the respiratory tract, and how these nerves are involved in controlling the cough response. Central to this are the Transient Receptor Potential (TRP) ion channels, a family of polymodal receptors that can be activated by such diverse stimuli as chemicals, temperature, osmotic stress, and mechanical perturbation. These ion channels are thought to be molecular pain integrators and targets for novel analgesic agents for the treatment of various pain disorders but some are also being developed as anti-tussives.

Indexed as

AnimalsAntitussive AgentsCoughDrug DesignDrug Evaluation, PreclinicalHumansModels, BiologicalRespiratory SystemRespiratory Tract DiseasesTransient Receptor Potential ChannelsAntitussive AgentsTransient Receptor Potential ChannelsAirway diseaseCoughRespiratory pharmacologySensory nerveTransient receptor potential

Identifiers

PMID23474212
PMCPMC3763377
OpenAlexW2035107123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.